Owner SGX Pharmaceuticals, Inc.

Inventors Bounaud, Pierre; Vaino, Andrew

Agent Spruson & Ferguson

Pub. Number AU-B-2004313947

PCT Pub. Number WO2005/068473

Priority 60/598,221 02.08.04 US; 60/530,111 17.12.03 US

Filing date 17 December 2004

Wipo publication date 28 July 2005

Acceptance publication date 31 March 2011

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/4188 (2006.01)

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

C07D 491/02 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 498/02 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/02 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or